34596-92-4

Basic information

• Product Name: Glycine, N-[(4-nitrophenyl)sulfonyl]-, 1,1-dimethylethyl ester
• CAS NO: 34596-92-4
• Molecular Formula: C12H16N2O6S
• Molecular Weight: 316.335
• Mol File: 34596-92-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Glycine, N-[(4-nitrophenyl)sulfonyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-[(4-nitrophenyl)sulfonyl]-, 1,1-dimethylethyl ester(34596-92-4)
• EPA Substance Registry System: Glycine, N-[(4-nitrophenyl)sulfonyl]-, 1,1-dimethylethyl ester(34596-92-4)

Safety Data

• Hazardous Substances Data: 34596-92-4(Hazardous Substances Data)

Upstream product

• 27532-96-3 glycine tert-butyl ester hydrochloride 
• 98-74-8 4-Nitrobenzenesulfonyl chloride 
• 6456-74-2 Glycine tert-butyl ester 

Relevant articles and documents

CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF

The invention describes membrane permeable creatine prodrugs, pharmaceutical compositions comprising membrane permeable creatine prodrugs, and methods of treating diseases such as ischemia, heart failure, neurodegenerative disorders and genetic disorders

DITHIAZOLE COMPOUNDS, MATRIX METALLOPROTEASE INHIBITORS AND EXTERNAL PREPARATIONS FOR THE SKIN

A dithiazole compound or a salt thereof expressed by formula (I): wherein R1, is hydrogen atom, alkyl, etc.; R2 is hydrogen atom, hydroxy, alkyl, aryl, arylalkoxy, arylalkyl, etc.; R3 is one group of formulae (II), (III) and (IV): This compound has an excellent inhibiting action on matrix metalloprotease (MMPs) activity, and is useful for pharmaceutical, cosmetic and skin external compositions.

Hydroxamic acid derivatives

The present invention relates to: (i) hydroxamic acid derivative of the formula (I): wherein R1 is hydrogen, or C1-4 alkyl; R2 is hydrogen, C1-8 alkyl, phenyl, C1-4 alkyl substituted by phenyl; E is -CONR3-, in which R3 is hydrogen, C1-4 alkyl, etc., -NR3